🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Length of hospitalization for COVID-19 infection may be increased due to th...
Status
Completed
Location
Chu Saint-Etienne
Start Date
2021-02-01
Trial ID
NCT05236478
Treatments Being Tested
Exercise during chemotherapy (CT) is a promising strategy to reduce fatigue...
Status
Unknown
Location
CHU de Besançon
Start Date
2018-08-03
Trial ID
NCT03400072
Treatments Being Tested
Obesity is currently a major public health challenge in France, particularl...
Status
Recruiting
Location
Clinique Elsan de Saint Omer
Start Date
2026-06-30
Trial ID
NCT07685483
Treatments Being Tested
Symptoms due to endometriosis cause psychological distress and interpersona...
Status
Unknown
Location
Upper Alsace University
Start Date
2023-05-29
Trial ID
NCT05831735
Treatments Being Tested
This is a pilot, prostective, comparative, randomized, monocentric open-lab...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05644197
Treatments Being Tested
This study is a randomised controlled trial designed to compare two adapted...
Status
Recruiting
Location
SMR Marc Sautelet
Start Date
2022-09-21
Trial ID
NCT06262269
Treatments Being Tested
Allogeneic haematopoietic stem cell transplantation (aHSCT) is the only cur...
Status
Completed
Location
Institut d'Hématologie et d'Oncologie Pédiatrique
Start Date
2022-05-25
Trial ID
NCT05298930
Treatments Being Tested
The ProActIF-01 trial aims to assess the feasibility of a supervised 8-week...
Status
Recruiting
Location
CHRU de Tours
Start Date
2023-04-08
Trial ID
NCT05441163
Treatments Being Tested
Adapted Physical Activity (APA) helps to prevent chronic diseases identifie...
Status
Terminated
Location
Maison Sport Santé 83
Start Date
2022-10-19
Trial ID
NCT05437978
Treatments Being Tested
Peripheral arterial disease (PAD) affects more than 200 million people worl...
Status
Unknown
Location
Peter Lougheed Center, Alberta Health Services, University of Calgary
Start Date
2019-02-15
Trial ID
NCT03839953
Treatments Being Tested